P-537 Cisplatin plus gemcitabine with or without vinorelbine as neoadjuvant therapy for radically-treatable stage II non small cell lung cancer (NSCLC). Preliminary results of a randomised study of the GON (grupo Oncológico del Norte de Espan˜a) | Publicación